Dallan Murray - Mar 3, 2025 Form 4 Insider Report for Sarepta Therapeutics, Inc. (SRPT)

Role
Chief Customer Officer
Signature
/s/ Cristin Rothfuss, as Attorney-in-Fact for Dallan Murray
Stock symbol
SRPT
Transactions as of
Mar 3, 2025
Transactions value $
-$73,780
Form type
4
Date filed
3/4/2025, 08:00 PM
Previous filing
Feb 13, 2025
Next filing
Mar 6, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SRPT Common Stock Tax liability -$73.8K -711 -3.2% $103.77 21.5K Mar 3, 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were sold by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 1, 2024.
F2 Amount of Securities Beneficially Owned includes 194 shares purchased under the Company's registered Employee Stock Purchase Plan on February 28, 2025.